CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 115 enrolled
Drug / intervention
High Intensity Quell +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05540002
NCT05540002N/ACompleted
CompareCT.gov

Efficacy of the Quell Wearable Device for Treatment of Central Sensitization-related Pain Among Persons With Chronic Overlapping Pain Conditions

Brigham and Women's Hospital·interventional·Posted Sep 14, 2022·Updated Mar 19, 2025

In Brief

A clinical study evaluating High Intensity Quell and Low Intensity Quell for Chronic Pain and 3 related conditions. Completed, enrolled 115 participants across 1 site.

Detailed Summary

This study will examine the pain-relieving effects of a transcutaneous electrical nerve stimulator device called a Quell for persons with multiple chronic overlapping pain conditions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain, Adults 21 and Older, Multiple Chronic Overlapping Pain Conditions, Hypersensitivity
CountriesUnited States
CollaboratorsNeuroMetrix, Inc.

Timeline

N/ACompletedFinished
2023202420252026
First PostedSep 14, 2022
Enrollment StartOct 14, 2022
Primary CompletionSep 19, 2024
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 3.8 years ago

Interventions

High Intensity Quelldevice

Participants will receive 1 hour of continuous stimulation during each therapy session. Subjects are asked to complete a minimum of 3 sessions per day.

Low Intensity Quelldevice

Participants will receive only three 2-minute periods of stimulation (at 0, 28, 58 minutes) during each 60-minute therapeutic session. Subjects are asked to complete a minimum of 3 sessions per day.